Synthetic Methods

1,3-didodecylpyrimidine-2,4,6(1H,3H,5H)-trione (2) -
To a solution of n-dedecyl amine (2.00 mL, 8.70 mmol) in 36 mL dichloromethane was added a solution of n-dodecyl isocyanate (2.10 mL, 8.70 mmol) in 36 mL dichloromethane under argon. The mixture was heated to reflux for 1 h. After malonyl chloride (0.85 mL, 8.70 mmol) was added, the mixture was heated at reflux for an additional hour. The mixture was allowed to cool to room temperature and was quenched with 1 N HCl (50 mL). The crude product was extracted with dichloromethane (3 x 50 mL) and the combined organic phases were washed with H 2 O (1 x 30 mL), dried over MgSO 4 and filtered. Solvent was removed under vacuo. Purification by flash column chromatography (hexane:EtOAc = 9:1 to 4:1) gave 4.01 g (99% yield) of the product as yellow solid. Characterization of this compound matched that of the previously reported compound. 1 1,3-didodecyl-5-(furan-2-ylmethylene)pyrimidine-2,4,6(1H,3H,5H)-trione -1,3-Didodecylpyrimidine-2,4,6(1H,3H,5H)-trione (2.00 g, 4.3 mmol) in H 2 O (8.6 mL) was treated with 2-furaldehyde (0.36 mL, 4.3 mmol). The mixture was stirred at room temperature for 21 h. The yellow waxy solid was extracted by dichloromethane (3 x 30 mL). Combined organic phases was dried over MgSO 4 , filtered and the solvent was removed in vacuo to give 2.17 g of pale yellow solid in 93 % yield; 1 5-((2Z,4E)-5-((6-azidohexyl)(ethyl)amino)-2-hydroxypenta-2,4-dien-1-ylidene)-1,3-didodecylpyrimidine-2,4,6(1H,3H,5H)-trione (3) -To a stirring solution of 1,3-didodecyl-5-(furan-2-ylmethylene)pyrimidine-2,4,6(1H,3H,5H)-trione (500 mg, 0.921 mmol) in THF (1 mL) was added a solution of 6-azido-N-ethylhexan-1-amine (173 mg, 1.013 mmol) in THF (1mL) and the mixture was stirred at rt for 20 minutes. Solvent was removed in vacuo and the product was purified by column chromatography using DCM:MeOH (100:0 to 99:1) system. Dark purple solid (397 mg) was obtained in 61 % yield; 1 
,6(1H,3H,5H)-trione (107 mg, 0.150 mmol) dissolved in minimum amount of acetone. The mixture was heated to 50 ºC in a water bath for 16 h. After the mixture was cooled to room temperature, the product was extracted with dichloromethane (4 x 20 mL). The crude product was precipitated twice into diethyl ether, yielding 123 mg (66 % yield) of DASA-amphiphile 4 as a purple solid.
Overlaid GPC Traces of DASA-Amphiphile and PEG
As seen in the below overlaid spectra of GPC, the molecular weight change from approximately 3000 Da (PEG, orange trace) to approximately 3700 Da (DASA-amphiphile, blue trace) has resulted in the peak shift to an earlier elution time. 
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Preparation of Micelle Solutions with Nile Red
The stock solutions were prepared according to the procedure used by Fréchet and coworkers. 2 Briefly, 12.5 μL of Nile Red stock solution in dichloromethane (0.05 mg/mL) was added to a 4 mL vial. This vial was placed under vacuum until the solvent was completely removed. An aqueous DASA-PEG amphiphile stock solution at concentration of 2 mg/mL was prepared and added to this vial. Deionized water was added to dilute the solution to 2 mL with desired concentration. This solution was stirred vigorously for 10 minutes and then allowed to equilibrate at room temperature for 1 hour. Figure S1 . Fluorescence emission spectrum of Nile red with varying concentrations of DASA-amphiphile 4 in water. At low concentrations, maximum emission occurs around 660 nm. As concentrations increase, maximum emission blue shifts indicating encapsulation of Nile red within the core of micelles. To verify that the disruption of micelle is being induced by the photoisomerization of the DASA segments, UV-Vis spectroscopy was employed ( Figure S3 ). A micellar solution was prepared and the change in absorbance of the DASA moiety  max = 553 nm) was monitored at different time intervals of visible light irradiation. After 1 hour of irradiation, the DASA absorbance decreased by ~80%. This observation confirms that the primary reason for micelle disruption is indeed the visible light-triggered photoisomerization of the DASA segments from 4 to 5. As the triene form of the DASA (the hydrophobic core of the micelles) becomes isomerized to a hydrophilic zwitterion by visible light, the amphiphilic character of the DASA-amphiphile 4 is lost, and thus the micellar structure is disintegrated. Of note, no special precautions are required to handle this material because ambient light does not trigger micelle disassembly without extended exposure (> 3 hours). In order to demonstrate the disassembly of the micelles with visible light, fluorescence spectroscopy was used to monitor the release of cargo with respect to irradiation time. Nile Red, a solvatochromic and hydrophobic dye that fluoresces at 660 nm with low emission intensity in water and at < 600 nm with enhanced emission intensity in hydrophobic environments, was chosen as the cargo. Upon irradiation, the intensity of fluorescence steadily decreased with a concurrent red-shift of the emission  max . This confirms that Nile Red is slowly released into the aqueous solution from the micelle core as the DASA segments of DASA-amphiphile 4 isomerize to their hydrophilic form of DASA-nonamphiphile 5 in response to visible light. We used dynamic light scattering (DLS) to verify that the micelles are disrupted when we shine light on them. Prior to light irradiation, solutions of DASA-amphiphile 4 above the critical micelle concentration (CMC) (0.5 mg/mL, see Supporting Information for determination of CMC) successfully formed micelles, whose average size was ~22 nm in diameter ( Figure S5 , left). Upon irradiation with visible light, the micelles rapidly disassembled because DASA moieties isomerize into hydrophilic zwitterions. After irradiation no particle greater than 3 nm could be detected by DLS ( Figure S5, right) . 
CMC Determination
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Preparation of a micelle solution with 1 µM of paclitaxel
A stock solution of paclitaxel in dichloromethane was prepared at 0.9 mg/mL concentration. 20 µL of this stock solution was added to a 1-dram vial equipped with a magnetic stir bar and the solvent was removed in vacuo. To this vial was added 1.0 mg of DASA-amphiphile 4 and 2.0 mL of deionized water. The mixture was stirred vigorously for 10 minutes and was allowed to equilibrate at room temperature for 1 hour.
Paclitaxel Content and Loading Efficiency
In this experiment, 0.135 mM (0.5 mg/mL) of DASA-amphiphile 4 and 1 µM (0.85 µg/mL) of paclitaxel was used, which is equivalent to 0.17 wt. % drug loading. After preparing the micelle solution loaded with paclitaxel, the solution was filtered through a molecular cut-off filter (EMD Millipore Amicon Ultra-4 Centrifugal Filter Units; Ultra-4; w/Ultracel-3 membrane; 3000 NMWL; Dia. x L: 17.2 x 73.4mm). The filtered solution was then analyzed to determine the efficiency of paclitaxel loading by reverse-phase HPLC on a preparative C 18 column (300 Å, 5 µm, 4.6 mm i.d. x 250 mm) with isocratic elution of wateracetonitrile (55:45 v/v) with a flow rate of 1.0 mL/min at 25 °C. First, a calibration curve was established using samples with known concentrations of paclitaxel ranging from 0 to 0.6 µM as shown below. It was found that the loading efficiency was greater than 99% (Integration was 264 for the sample and elution time was 8.8 min). It is known that with low drug content (below 30 wt.%) the drug loading efficiency is generally high (>90%). 
Cell Culture and Sample Preparation
As recommended by the ATCC, MCF-7 human breast cancer cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin, and these cells were grown in a humidified incubator maintained at 37 °C and 5% CO 2 . Before live-cell imaging, cancer cells were harvested with TrypLE express reagent (Life Technologies) following the manufacturer's protocol. The harvested cells were then seeded on a 24-well culture plate or a 96-well black microplate. After 24-hour incubation, the medium was aspirated and discarded, and the cells were washed with pre-warmed DPBS twice. Immediately, the washed cells were incubated with each sample either in presence or absence of visible light for an hour. The treated cells were twice washed with pre-warmed DPBS gently and added by a phenol red-free, fresh medium before following experiments.
Quantification of Nile Red Delivery
To quantify the amount of Nile Red delivered in cancer cells, the MCF-7 adherent cells transferred in a black 96-well microplate were treated with Nile Red-loaded DASA-amphiphile 4 samples in presence or absence of visible light for an hour and subsequently washed with DPBS to remove undelivered cargos. After addition of fresh DPBS, the fluorescence of Nile red delivered in each cell sample was measured with a microplate reader (Infinite M1000, Tecan, San Jose, CA). For calibration, the cancer cells were incubated with free Nile Red with the concentration ranging from 1 to 10 µm at the same time, and the fluorescence of free Nile Red absorbed in each cell sample was detected as described above. Based on the relationship between the Nile Red concentration and the fluorescent signal, the quantity of Nile Red delivered to the cells were calculated, and all measurements were performed in triplicate.
Cell Viability Measurement
The viabilities of treated MCF-7 cancer cells were measured at each time point via LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cells (Life Technologies) according to the manufacturer's protocol. At each time point, cell samples in a black 96-well microplate were stained by calcein acetoxymethyl ester specific for viable cells and ethidium momodimer-1 specific for nonviable cells. The cell viabilities were subsequently analyzed with a microplate reader (Infinite M1000, Tecan, San Jose, CA), and all measurements were performed in triplicate. 
